Gould LH, et al.
Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clinical Infectious Diseases
2009; 49: 1480–1485.
Tuttle J, et al.
Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiology and Infection
1999; 122: 185–192.
Escherichia coli O157. Lancet
2010; 376: 1428–1435.
Roberts JA, Upton PA, Azene G.
Escherichia coli O157:H7; an economic assessment of an outbreak. Journal of Public Health Medicine
2000; 22: 99–107.
Wells JG, et al.
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. Journal of Clinical Microbiology
1983; 18: 512–520.
Belongia EA, et al.
Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. Journal of the American Medical Association
1993; 269: 883–888.
Wahl E, et al.
Investigation of an Escherichia coli O145 outbreak in a child day-care centre – extensive sampling and characterization of eae- and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infectious Diseases
2011; 11: 238.
Miliwebsky E, et al.
Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Revista Argentina de Microbiologia
2007; 39: 90–92.
Shah S, et al.
Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center. Clinical Infectious Diseases
1996; 23: 835–836.
Willshaw GA, et al.
Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995–1998. Journal of Medical Microbiology
2001; 50: 135–142.
Jenkins C, et al.
Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli
. Journal of Medical Microbiology
2012; 61: 1082–1085.
Health Protection Agency. Investigation of faecal specimens for bacterial pathogens. National Standard Method, BSOP 30, Issue 7, 2010.
Karch H, et al.
Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. Journal of Clinical Microbiology
1995; 33: 1602–1605.
Brown JA, et al.
Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado. Pediatric Infectious Disease Journal
2012; 31: 384–388.
Chapman PA, Wright DJ, Siddons CA. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. Journal of Medical Microbiology
1994; 40: 424–427.
Boyce TG, Swerdlow DL, Griffin PM.
Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine
1995; 333: 364–368.
Pai CH, et al.
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. Journal of Infectious Diseases
1988; 157: 1054–1057.
Wong CS, et al.
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine
2000; 342: 1930–1936.
Pavia AT, et al.
Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. Journal of Pediatrics
1990; 116: 544–551.
Ikeda K, et al.
Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompan ying Escherichia coli O157:H7 infection. Clinical Nephrology
1999; 52: 357–362.
Proulx F, et al.
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. Journal of Pediatrics
1992; 121: 299–303.
Safdar N, et al.
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. Journal of the American Medical Association
2002; 288: 996–1001.
Nitschke M, et al.
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. Journal of the American Medical Association
2012; 307: 1046–1052.
Seifert ME, Tarr PI. Therapy: azithromycin and decolonization after HUS. Nature Reviews Nephrology
2012; 8: 317–318.
Snedeker KG, et al.
Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infectious Diseases
2009; 9: 144.
Parry SM, Salmon RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerging Infectious Diseases
1998; 4: 657–661.
Al-Jader L, et al.
Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Archives of Disease in Childhood
1999; 81: 60–63.
Lerman Y, et al.
A cluster of cases of Escherichia coli O157 infection in a day-care center in a communal settlement (Kibbutz) in Israel. Journal of Clinical Microbiology
1992; 30: 520–521.
Reida P, et al.
An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. Zentralblatt fur Bakteriologie
1994; 281: 534–543.
Gilbert M, et al.
Screening policies for daycare attendees: lessons learned from an outbreak of E. coli O157:H7 in a daycare in Waterloo, Ontario. Canadian Journal of Public Health
2008; 99: 281–285.
Tam CC, et al.
Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut
2012; 61: 69–77.
Vogelsang E, Pulz M. Environmental studies of asymptomatic kindergarten children as carriers of enterohemorrhagic Escherichia coli (EHEC) in the Ammerland district [in German]. Gesundheitswesen
1999; 61: 38–44.
Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet
1997; 349: 745–746.